Moustafa Abdou: Tumor Lysis Syndrome Is a Preventable but Life-Threatening Oncologic Emergency
Moustafa Abdou, Author and Founder of AskHematologist.com, shared a post on LinkedIn:
”Tumor Lysis Syndrome (TLS): Preventable, Yet Potentially Fatal
Tumor Lysis Syndrome remains one of the most critical oncologic emergencies in clinical practice. Rapid tumor cell breakdown can lead to severe metabolic disturbances, including hyperkalemia, hyperuricemia, and acute kidney injury, with potentially life-threatening consequences.
Importantly, TLS is no longer confined to high-grade lymphomas and acute leukemias. With the increasing use of targeted therapies, it is now recognized across a broader spectrum of malignancies.
Early risk stratification, close monitoring, and timely intervention, including hydration and appropriate use of agents such as rasburicase, are essential to improving patient outcomes.”
Stay updated with Hemostasis Today.
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service
-
Sep 27, 2026, 15:38Jessica Garcia: Standing Where VWD Was First Recognized 100 Years Later
-
Sep 27, 2026, 15:37Heghine Khachatryan: A Meaningful Step Forward for Inherited Blood Disorders in Africa